About Nanomedic

Nanomedic Technologies Ltd. is an Israeli bio-medical therapeutics technology company specializing in the development and manufacturing of its innovative Spincare System platform for advanced wound treatment.

Founded in 2018, as a spinoff of Nicast, a pioneer in electrospinning technology, Nanomedic concentrates on its unique Portable Electrospinning technology platform, the Spincare® system.

The company, located in the center of worldwide known microenvironment of outstanding innovation companies, has set the goal to change paradigms in wound care treatment, envisioning the ultimate solution of artificial skin 3D printing directly on patients’ wounds.

The Spincare system was first put on the market in Q3-2020 and is now distributed and sold in more than 40 countries on five continents.

Management

CEO

Hezy Aspis

Mr. Aspis has more than 30 years of experience in engineering and management in the electronic and medical device industries. He brings to Nanomedic his vast knowledge & experience in R&D, production, marketing, and business management of high-tech projects, in a very competitive international environment. Mr. Aspis holds a BSc degree from the Technion- Israel Institute of Technology and an MBA degree from Tel-Aviv University.
CTO

Dr. Claudia M. Barzilay

Dr. Barzilay has over 20 years of recognized research and development experience in the field of Pharma, Biotech and Medical Devices. Prior to joining Nanomedic, Claudia served as Project Manager, Scientific Advisor and VP R&D, in local and global biotech and cleantech companies gaining broad knowledge in Product Development. She received her Ph.D. in Chemistry from the Technion- Israel Institute of Technology, pursued postdoctoral research at Stanford University, CA- USA and achieved a Researcher and Lecturer position at the Faculty of Medicine, Hebrew University of Jerusalem.
VP Finance

Chanan Morris

Mr. Morris has more than 25 years of managerial, financial and operations experience and has expertise in complex financial arrangements dealing with private investment, disposition of assets, WOFEs, and joint ventures. Chanan has spent the last 16 years managing many of the Infinity groups top portfolio companies and today also serves as the CFO of Imed Infinity Medical (TASE: IMED). Chanan holds a BSc in Accounting from Northeastern University (USA).
VP QA/RA

Asher Zilberstein

Mr. Zilberstein has more than 24 years of experience in the establishment and management of quality and regulation assurance activities in the global medical device industry.
Prior to joining Nanomedic, Asher served as the QA/RA leader in several medical device companies such as Endospan (endovascular aortic repair system), and Edwards’ acquired Valtech Cardio (transcatheter repair of heart valves). Asher holds a Master of Science (MSc) in Biotechnology from the Hebrew University in Jerusalem, Israel.
Head of Global Sales & Marketing

Kjetil Moen

Mr. Moen brings more than twenty-five years of wound care expertise to Nanomedic.
Most of that time has been used to build brands in the international marketplace and develop and manage international sales and distribution structures throughout the globe. Previous companies include Molnlycke Health Care, Ferris Mfg. Corp (PolyMem), and Curea Medical.
Operations Manager

Rafi Tzvick

Mr. Tzvick has more than 20 years of experience in development and implementation of operational policies and procedures, in particular of clean rooms and aseptic processes, ensuring regulatory compliance in pharma and medical device companies. Previous companies include TransPharma Medical and Ornim Medical.
CEO

Hezy Aspis

Mr. Aspis has more than 30 years of experience in engineering and management in the electronic and medical device industries. He brings to Nanomedic his vast knowledge & experience in R&D, production, marketing, and business management of high-tech projects, in a very competitive international environment. Mr. Aspis holds a BSc degree from the Technion- Israel Institute of Technology and an MBA degree from Tel-Aviv University.
CTO

Dr. Claudia M. Barzilay

Dr. Barzilay has over 20 years of recognized research and development experience in the field of Pharma, Biotech and Medical Devices. Prior to joining Nanomedic, Claudia served as Project Manager, Scientific Advisor and VP R&D, in local and global biotech and cleantech companies gaining broad knowledge in Product Development. She received her Ph.D. in Chemistry from the Technion- Israel Institute of Technology, pursued postdoctoral research at Stanford University, CA- USA and achieved a Researcher and Lecturer position at the Faculty of Medicine, Hebrew University of Jerusalem.
VP Finance

Chanan Morris

Mr. Morris has more than 25 years of managerial, financial and operations experience and has expertise in complex financial arrangements dealing with private investment, disposition of assets, WOFEs, and joint ventures. Chanan has spent the last 16 years managing many of the Infinity groups top portfolio companies and today also serves as the CFO of Imed Infinity Medical (TASE: IMED). Chanan holds a BSc in Accounting from Northeastern University (USA).
VP QA/RA

Asher Zilberstein

Mr. Zilberstein has more than 24 years of experience in the establishment and management of quality and regulation assurance activities in the global medical device industry.
Prior to joining Nanomedic, Asher served as the QA/RA leader in several medical device companies such as Endospan (endovascular aortic repair system), and Edwards’ acquired Valtech Cardio (transcatheter repair of heart valves). Asher holds a Master of Science (MSc) in Biotechnology from the Hebrew University in Jerusalem, Israel.
Head of Global Sales & Marketing

Kjetil Moen

Mr. Moen brings more than twenty-five years of wound care expertise to Nanomedic.
Most of that time has been used to build brands in the international marketplace and develop and manage international sales and distribution structures throughout the globe. Previous companies include Molnlycke Health Care, Ferris Mfg. Corp (PolyMem), and Curea Medical.
Operations Manager

Rafi Tzvick

Mr. Tzvick has more than 20 years of experience in development and implementation of operational policies and procedures, in particular of clean rooms and aseptic processes, ensuring regulatory compliance in pharma and medical device companies. Previous companies include TransPharma Medical and Ornim Medical.

Directors

Active Chairman

Chen Katz

CEO of TechnoPlus Venture, a diversified public investment company, traded on the Tel-Aviv Stock Exchange (TASE: TNPV) since 1999. Mr. Chen Katz Possesses extensive experience in managing investments in companies and ventures of all maturity levels.
Director

John R. Harper, Ph.D

With more than 35 years' of experience, Dr. Harper currently serves as a Senior Medical Scientist in the Medical Solutions Division of 3M Health Care, where he is responsible for early-stage discovery and innovation related to advanced wound care. Dr. Harper previously served as Chief Technology Officer for 3M affiliate KCI, where he was responsible for innovation and technology development at the company's Center for Advanced Research and Technology. He also served as Vice President of Clinical Development and Clinical Sciences at biotechnology company LifeCell Corporation. Dr. Harper earned his Ph.D. in Biochemistry from the University of Texas Graduate School of Biomedical Sciences and M.D. Anderson Cancer Center.
Director

Erez Rozenfeld

Mr. Rozenfeld has a proven track record in global business development in the field of medical devices. He has overseen mergers and acquisitions. Mr. Rozenfeld had managerial positions in Lumenis UK, Aesthera Inc., RapiX and V-Wave as well as publicly traded companies as Teva Group and Agis.
Director

Gideon Petrover

Partner in Om-Maya, a private equity firm. Management experience in multinational corporation, focus in management and operations, information management.
Active Chairman

Chen Katz

CEO of TechnoPlus Venture, a diversified public investment company, traded on the Tel-Aviv Stock Exchange (TASE: TNPV) since 1999. Mr. Chen Katz Possesses extensive experience in managing investments in companies and ventures of all maturity levels.
Director

John R. Harper, Ph.D

With more than 35 years' of experience, Dr. Harper currently serves as a Senior Medical Scientist in the Medical Solutions Division of 3M Health Care, where he is responsible for early-stage discovery and innovation related to advanced wound care. Dr. Harper previously served as Chief Technology Officer for 3M affiliate KCI, where he was responsible for innovation and technology development at the company's Center for Advanced Research and Technology. He also served as Vice President of Clinical Development and Clinical Sciences at biotechnology company LifeCell Corporation. Dr. Harper earned his Ph.D. in Biochemistry from the University of Texas Graduate School of Biomedical Sciences and M.D. Anderson Cancer Center.
Director

Erez Rozenfeld

Mr. Rozenfeld has a proven track record in global business development in the field of medical devices. He has overseen mergers and acquisitions. Mr. Rozenfeld had managerial positions in Lumenis UK, Aesthera Inc., RapiX and V-Wave as well as publicly traded companies as Teva Group and Agis.
Director

Gideon Petrover

Partner in Om-Maya, a private equity firm. Management experience in multinational corporation, focus in management and operations, information management.

Scientific Board

Scientific Board Member

Professor Josef Haik, M.D; MPH

Prof. Dr. Josef Haik (born 1966, Ramat Gan, Israel) is a specialist in Aesthetic & Reconstruction Plastic Surgery and Burns. Prof Haik is the director of the National Intensive Care Burn Unit and Director of the Division of Plastic & Reconstructive at the Sheba Medical Center, Tel Hashomer Hospital, Ramat Gan Israel, affiliated to the Tel Aviv University. Prof. Haik is a Professor in the Faculty of Surgery at Tel Aviv University. Prof Haik completed his medical studies in 1994 at the University of Bologna, Italy and is a specialist in plastic surgery since 2002. Prof Haik completed felowship in Plastic Surgery in Sao Paulo, Brazil and in the ICU, Burns in the Hospital of the University of Alberta, Canada. Prof. Haik has a Master Degree in Public Health (MPH), Disasters management since 2008. Prof Haik is a member and chairman of the American Burn Association. He is a member in the Israeli Association for Aesthetic plastic surgery, the Israel Medical Association, the International Association for Aesthetic Surgery and the Israeli Association for healing wounds. Prof. Haik contributed to chapters in medical textbooks and published numerous articles.
Scientific Board Member

Professor Jan Plock, M.D.

Prof. Plock currently serves as Chief of Plastic Surgery and Hand Surgery at the Aarau Canton Hospital (KSA), the largest hospital in the Aargau region, and one of the three largest hospital centers in Switzerland. He previously served in multiple roles at University Hospital Zurich, including Director of the Burn Center, Director of the Reconstructive Transplantation Program, and Director of the Post-Bariatric Body-Contouring Program. He was made a Fellow of the European Board of Plastic Surgeons in 2009 and earned his Adjunct Professorship from the University of Zurich in 2020.
Scientific Board Member

Professor Josef Haik, M.D; MPH

Prof. Dr. Josef Haik (born 1966, Ramat Gan, Israel) is a specialist in Aesthetic & Reconstruction Plastic Surgery and Burns. Prof Haik is the director of the National Intensive Care Burn Unit and Director of the Division of Plastic & Reconstructive at the Sheba Medical Center, Tel Hashomer Hospital, Ramat Gan Israel, affiliated to the Tel Aviv University. Prof. Haik is a Professor in the Faculty of Surgery at Tel Aviv University. Prof Haik completed his medical studies in 1994 at the University of Bologna, Italy and is a specialist in plastic surgery since 2002. Prof Haik completed felowship in Plastic Surgery in Sao Paulo, Brazil and in the ICU, Burns in the Hospital of the University of Alberta, Canada. Prof. Haik has a Master Degree in Public Health (MPH), Disasters management since 2008. Prof Haik is a member and chairman of the American Burn Association. He is a member in the Israeli Association for Aesthetic plastic surgery, the Israel Medical Association, the International Association for Aesthetic Surgery and the Israeli Association for healing wounds. Prof. Haik contributed to chapters in medical textbooks and published numerous articles.
Scientific Board Member

Professor Jan Plock, M.D.

Prof. Plock currently serves as Chief of Plastic Surgery and Hand Surgery at the Aarau Canton Hospital (KSA), the largest hospital in the Aargau region, and one of the three largest hospital centers in Switzerland. He previously served in multiple roles at University Hospital Zurich, including Director of the Burn Center, Director of the Reconstructive Transplantation Program, and Director of the Post-Bariatric Body-Contouring Program. He was made a Fellow of the European Board of Plastic Surgeons in 2009 and earned his Adjunct Professorship from the University of Zurich in 2020.

Join our team

Do you want to be part of our team?
Come work with us and change the world of wound care.

Apply now